Skip to content
Screener

Nutex Health Inc. NUTX Q3 2025 earnings

Reported November 19, 2025 · After market close

Revenue$267.8MBeat by $54.0M
EPS$7.76Beat by $5.95
Revenue estimate$213.8M
EPS estimate$1.81

Next report

Nov 17, 2026 (in 2 months)
Revenue estimate$215.0M
EPS estimate$5.71

Financials

Q3 2025

Income statement

See full
Revenue$267.8M+240%
Gross profit$154.9M+607%
Operating income$130.4M+1,249%
Net income$55.4M+731%
EPS (diluted)$7.76+551%

Balance sheet

See full
Cash & equivalents$166.0M+254%
Total debt$353.3M+17.8%
Total equity$317.2M+425%
Total assets$964.5M+120%

Cash flow

See full
Operating cash flow$99.5M+1,366%
CapEx$302.0K-51.1%
Free cash flow$99.2M+1,508%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$573.95M+422%
Enterprise value$761.2M+110%
P/E4.8×—
P/S0.6×+0.2×

Profitability

See full
Gross margin55%+31.8pp
Operating margin36.6%+33.8pp
Net margin12.3%+8.0pp
FCF margin18%+11.1pp

Returns & leverage

See full
Return on equity63.9%+43.7pp
Debt / equity1.1×-3.8×
Current ratio3.2×+1.4×

FAQ

When did Nutex Health Inc. report Q3 2025 earnings?
Nutex Health Inc. (NUTX) reported Q3 2025 earnings on November 19, 2025 after market close.
What were Nutex Health Inc.'s Q3 2025 revenue and EPS?
Nutex Health Inc. reported revenue of $267.8M and eps of $7.76 for Q3 2025.
Did Nutex Health Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $213.8M by $54.0M. EPS beat the consensus estimate of $1.81 by $5.95.
How did Nutex Health Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 239.9% from $78.8M a year earlier.
Where can I find Nutex Health Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-052962) and the 10-Q/A periodic report (0001628280-25-052951) directly on SEC EDGAR. The filing index links above go to sec.gov.